C1 esterase inhibitor recombinant Intravenous and Larotrectinib Capsules
Determining the interaction of C1 esterase inhibitor recombinant Intravenous and Larotrectinib Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: C1 esterase inhibitor (human)
Brand name: Berinert, Cinryze, Haegarda, Ruconest
Synonyms: Complement C1 esterase inhibitor, C1 Inhibitor (Human)
Generic Name: larotrectinib
Brand name: Vitrakvi
Synonyms: Larotrectinib
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- C1 esterase inhibitor recombinant Intravenous-Larotrectinib Oral Solution
- C1 esterase inhibitor recombinant Intravenous-Larotrectinib Sulfate
- C1 esterase inhibitor recombinant Intravenous-Lartruvo
- C1 esterase inhibitor recombinant Intravenous-Larynex
- C1 esterase inhibitor recombinant Intravenous-Laryng-O-Jet
- C1 esterase inhibitor recombinant Intravenous-Laryngesic
- Larotrectinib Capsules-C1 esterase inhibitor, human Intravenous
- Larotrectinib Capsules-C1 Inhibitor (Human)
- Larotrectinib Capsules-C1 Inhibitor (Human) (Berinert)
- Larotrectinib Capsules-C1 Inhibitor (Human) (Cinryze)
- Larotrectinib Capsules-C1 Inhibitor (Human) (Haegarda)
- Larotrectinib Capsules-C1 Inhibitor (Recombinant)